Genexine Inc
KOSDAQ:095700
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Genexine Inc
KOSDAQ:095700
|
KR |
|
S
|
Societe BIC SA
OTC:BICEF
|
FR |
|
Superbag Co Ltd
TSE:3945
|
JP |
|
K
|
Koh Brothers Group Ltd
SGX:K75
|
SG |
|
Northern Trust Corp
NASDAQ:NTRS
|
US |
|
A
|
A2A SpA
DUS:EAM
|
IT |
|
N
|
NHN KCP Corp
KOSDAQ:060250
|
KR |
|
C
|
CP All PCL
SET:CPALL
|
TH |
|
Canterra Minerals Corp
OTC:CTMCF
|
CA |
|
C
|
Cell Biotech Co Ltd
KOSDAQ:049960
|
KR |
|
Ascelia Pharma AB
STO:ACE
|
SE |
|
Cameco Corp
TSX:CCO
|
CA |
|
E
|
eXoZymes Inc
NASDAQ:EXOZ
|
US |
|
Nousouken Corp
TSE:3541
|
JP |
|
G
|
GCCP Resources Ltd
SGX:41T
|
MY |
|
F
|
Fanuc Corp
XMUN:FUC
|
JP |
Bankruptcy Probability
Genexine Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Genexine Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KR |
G
|
Genexine Inc
KOSDAQ:095700
|
131.9B KRW |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
466.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
205.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
187.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
130.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
81.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
63.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
54.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
84.1B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
52.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
42.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Genexine Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Genexine Inc has total debt of 105.8B KRW. This includes both short-term (101.2B KRW) and long-term (4.6B KRW) debt.
You can find a full breakdown on its Balance Sheet.